A Comparison of Two Treatment Strategies in Older Participants With Type 2 Diabetes Mellitus (T2DM)
Public ClinicalTrials.gov record NCT02072096. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Individualized treatMent aPproach for oldER patIents: A Randomized, Controlled stUdy in Type 2 Diabetes Mellitus (IMPERIUM)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to compare the benefits and risks associated with the use of 2 treatment strategies to lower blood sugar in participants aged 65 and older with T2DM. One strategy is based on the use of oral and injectable medications that only reduce blood sugar (glucose) when it is high. The other strategy is based on non-glucose dependent agents. The trial will last up to 72 weeks for each participant.
Study identification
- NCT ID
- NCT02072096
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 192 participants
Conditions and interventions
Conditions
Interventions
- Glimepiride Drug
- Metformin Drug
- Pioglitazone Drug
- Acarbose Drug
- Linagliptin Drug
- Sitagliptin Drug
- Liraglutide Drug
- Insulin Glargine Drug
- Exenatide once weekly (QW) Drug
- Exenatide twice daily (BID) Drug
Drug
Eligibility (public fields only)
- Age range
- 65 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2014 (Type not available)
- Primary completion
- Oct 2015 (Actual)
- Completion
- Oct 2015 (Actual)
- Last update posted
- Oct 9, 2019
2014 – 2015
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| New Horizon Research Center | Miami | Florida | 33175 | — |
| Suncoast Clinical Research | New Port Richey | Florida | 34652 | — |
| Florida Hospital | Orlando | Florida | 32804 | — |
| Athens Primary Care | Athens | Georgia | 30606 | — |
| Herman Clinical Research, LLC | Suwanee | Georgia | 30024 | — |
| Rocky Mountain Diabetes and Osteoporosis Center | Idaho Falls | Idaho | 83404 | — |
| Iderc, P.L.C. | Des Moines | Iowa | 50314 | — |
| Cotton O'Neil Clinic | Topeka | Kansas | 66606 | — |
| Mercy Health Research | St Louis | Missouri | 63141 | — |
| Southern New Hampshire Diabetes and Endocrinology | Nashua | New Hampshire | 03063 | — |
| Heritage Valley Medical Group, Inc. | Beaver | Pennsylvania | 15009 | — |
| Family Medical Associates | Levittown | Pennsylvania | 19056 | — |
| Carolina Health Specialists | Myrtle Beach | South Carolina | 29572 | — |
| Dallas Diabetes Endocrine Center | Dallas | Texas | 75230 | — |
| Rockwood Clinic Research Center | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02072096, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2019 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02072096 live on ClinicalTrials.gov.